Current data indicate that temporary ventricular support in patients who cannot be weaned from cardiopulmonary bypass is a reasonable and therapeutic treatment to extend life. Ventricular recovery and quality of life are satisfactory in long-term hospital survivors, and noncardiac disability is rare. Although the role of temporary ventricular support for acute myocardial infraction and cardiogenic shock is undefined, the expansion of indications to include these patients is reasonable and future clinical trials are warranted.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Jan 1 1987|
All Science Journal Classification (ASJC) codes